Nicotine Treatment of Impulsivity in Parkinson's Disease
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The specific aims of this study are to examine whether treatment with transdermal nicotine
improves computer-based laboratory and clinical measures of impulsive and compulsive
behaviors in Parkinson's Disease subjects who have recently experienced an impulse control
disorder.
Phase:
Phase 4
Details
Lead Sponsor:
University of Vermont
Collaborators:
Parkinson's Disease Foundation The Parkinson Study Group